• Who we are
    • About GARDP
    • Strategy
      • 5 BY 25
    • Our Team
    • Partners
    • GARDP Worldwide
  • What we do
    • Antibiotic resistance response
    • Pandemic Preparedness
    • Research & Development
      • Discovery & Exploratory Research
      • Children’s antibiotics
      • Sexually transmitted infections
      • Serious bacterial infections
    • Access to Antibiotics
    • REVIVE: Education & Collaboration
    • SECURE: Expanding Sustainable Access to Antibiotics
  • News & resources
    • Press centre
    • Updates
    • Events
    • Stories
    • Viewpoints
    • Publications
    • 日本語資料
  • Take action
    • Learn about antibiotics
    • Become a partner
    • Donate
    • Work for GARDP
    • Request for Proposals
    • Contact us
  • Donate

Hard to Study, Hard to Treat: Putting Children at the Centre of Antibiotic Research and Development


3 Jun 2019

by Balasegaram M., Pécoul B., Gray G., Sharland M., Swaminathan, S.

Lancet Infectious Diseases. 2019 ; 19 : 573-574. Available from : https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(19)30214-2/fulltext

Download as: PDF


More Scientific Articles

← R&D for Children’s Antibiotics: A Wake-up Call
Antimicrobial Resistance – Moving Forward? →

Programmes

Discovery & exploratory
Children’s antibiotics
Sexually transmitted infections
Serious bacterial infections
Access to Antibiotics

More GARDP sites

REVIVE: Education & Collaboration

Contact us

Contacts
Vacancies
Request for Proposals

Sign up to our newsletter to stay connected

Subscribe
  • Terms of use